Investor, entrepreneur, husband, and Dad. @MenloVentures. Previously: Illumina Ventures, Roche Ventana, Biodesy, Affymetrix.
Palo Alto, CA
Joined October 2013
- Tweets1.1K
- Following345
- Followers1.3K
- Likes2.7K
Greg Yap retweeted
At the start of this year, @joshim5 told me 2026 would be the "year of deployment" for @chaidiscovery
That wasn't just an aspiration — Chai has now signed its 6th pharma deal in the past 9 months:
Lilly
Pfizer
Novartis
argenx
BMS
and now with GSK:
endpoints.news/chai-discover…
Greg Yap retweeted
Thrilled to announce our $400M Series C led by @IndexVentures, with @kleinerperkins, @sequoia, @_DimensionCap and others.
Great to speak to @m_delamerced @nytimes about how drug discovery using AI is moving from a promise to actual deployment.
Congrats to @joshim5 @jackdent and @chaidiscovery on Series C and for continuing to push the frontier of AI in drug discovery toward deployment at scale! Excited to continue to collaborate @MenloVentures
Tomorrow's medicines should be designed with the precision and scale of modern engineering.
I'm thrilled that @ChaiDiscovery has raised a $400M Series C at a $3.8B valuation from @IndexVentures @KleinerPerkins @Sequoia @_DimensionCap to accelerate progress towards that goal.
Congrats to @chaidiscovery and @Novartis teams for the new collaboration and to see deployment of Chai-3 at scale!
I'm delighted to announce a new collaboration between @ChaiDiscovery & @Novartis.
It's been a pleasure working together over the past year, and we're excited to scale our collaboration to support broader deployment of Chai-3 across multiple therapeutic programs.
Greg Yap retweeted
Neural networks might speak English, but they think in shapes.
Understanding their rich *neural geometry* is key to understanding how they work – and to debugging and controlling them with precision.
Starting today, we’re releasing a series of posts on this research agenda. 🧵
Congrats to @Forbes' AI 50, including @MenloVentures portfolio companies @chaidiscovery, @AnthropicAI, and more! Go @joshim5 and @jackdent!
Proud to see so many Menlo-backed companies on the Forbes AI 50 list this year, and @Accordance, @axiommathai, @flappyairplanes, @OpenRouter and @WisprFlow on the inaugural Brink list for early-stage startups. Congrats! 🎉
Greg Yap retweeted
𝐀𝐈 𝐍𝐞𝐰𝐬: Checking in with @MenloVentures' Partner @grgyap to get his take on the latest trends in AI in healthcare.
Full video: biotechtv.com/post/menlo-ven…
Greg Yap retweeted
The rise of Anthropic in our data this year was one of the most notable headlines, increasing from 12% market share the first year we ran the survey to 40% this year, and an even more eye-opening 54% in code
The momentum is more than a vibe shift (though plenty of that too, especially on the TL as of late), but evidence of sustained value accrual to the frontier in LLM markets -- with Anthropic at the lead
Greg Yap retweeted
We’re thrilled to announce our collaboration with @EliLillyandCo.
We’ll be deploying Chai’s AI models to power biologics discovery across a broad set of drug programs at Lilly.
This is a major step forward in pharma’s adoption of AI-native R&D.
Congrats to @joshim5 @jackdent @chaidiscovery on their first major deal announcement with Eli Lilly! Always amazing to see their pace to adoption. 2026 looks like the tipping point in pharma adoption of AI tools up and down the stack! endpoints.news/eli-lilly-cha…
Greg Yap retweeted
Menlo Ventures is announcing a $16 million seed investment in @AuroraTher!
More than 350 million people worldwide live with over 7,000 rare diseases.
Aurora is building the first platform for treating rare genetic mutations that have historically been impossible to address at scale.
We’re proud to have incubated Aurora and we’re excited about the team being built. Congratulations to Professors Jennifer Doudna and @UrnovFyodor, and Edward Kaye.
Read more from @grgyap and Johnny Hu here: mnlo.vc/building-aurora
Great article on launch of @AuroraTher and our vision on how CRISPR can realize its promise of personalized treatments for every patient with rare genetic disease. @UrnovFyodor @MenloVentures endpoints.news/gene-editing-…
Congrats to @chaidiscovery @joshim5 @jackdent on Series B! Amazing progress pushing frontier of foundation models for antibody development and excited about early pharma feedback and translation into programs. @MenloVentures bloomberg.com/news/articles/…
Just released: new @MenloVentures report on enterprise AI adoption! Builds on our recent healthcare report - healthcare is #1 industry in AI adoption! Anthropic #1 enterprise model and increasing lead over OpenAI driven by coding! Read the report: mnlo.vc/enterprise-ai-25
Greg Yap retweeted
Today, we’re releasing new data showing that Chai-2 can design antibodies against challenging targets with atomic precision.
>86% of our designs possess industry-standard drug-quality properties without any optimization.
Thread👇
Congrats to @enfeinberg and @genesistxai on release of Pearl!
Introducing Pearl: the first co-folding model to outperform AlphaFold 3 in protein-ligand structure prediction – a critical step in rational drug design.
Thanks to our world-class ML team and @NVIDIA collaborators! Full technical report: genesis.ml/wp-content/upload…
#pearlAI
Today from @MenloVentures: healthcare leads other industries in AI adoption! Providers lead. Startups have won 85% of AI spend, but incumbents fighting back. Data and insight from 700+ healthcare execs: mnlo.vc/HealthcareAI_25 @derekgxiao @jpsanday @CroomBeatty
Congrats to @deedydas on your well deserved promotion! You've been a fantastic partner to all of us @MenloVentures on all things AI! More great things ahead!
Greg Yap retweeted
.@grgyap, Partner at @MenloVentures, shares how generative AI is profoundly changing drug discovery:
"It offers you the potential to create new molecules that have never been thought of by humans before."
"Now you have an opportunity to... make a drug by seeing inside the lock, understanding the structure of that lock, and trying to make a key that actually fits that space."
Watch the full episode on bit.ly/3JmJlpC. Hosted by @akashpasricha every weekday at 10 am PT / 1 pm ET.